Amorepacific

Last updated January 31, 2026

Innovation Areas

1,390

Inventors

Collaborations

Topical cortisone reductase inhibitors: AmorepacificRecent Research Landscape

Skin inflammation and aging are driven by unregulated cortisol and mineralocorticoid activity. These formulations utilize specific Palmarosa oil fractions to biochemically block receptor activation and enzymatic reduction.

What technical problems is Amorepacific addressing in Topical cortisone reductase inhibitors?

Excessive cutaneous inflammatory response

(8)evidences

External stressors cause cellular fatigue and inflammatory responses that degrade skin health. Mitigating these stressors prevents premature aging and maintains tissue integrity.

Impaired epidermal barrier function

(6)evidences

Loss of structural cohesion and moisture retention in the skin leads to increased sensitivity and environmental damage. Restoring this integrity prevents transepidermal water loss and pathological skin conditions.

Insufficient epidermal moisture retention

(2)evidences

Inadequate moisture retention and transepidermal water loss. Restoring hydration levels prevents skin irritation and structural degradation.